- Report
- September 2022
- 141 Pages
Global
From €4147EUR$4,750USD£3,591GBP
- Report
- September 2022
- 30 Pages
Global
From €2401EUR$2,750USD£2,079GBP
- Report
- September 2022
- 30 Pages
Global
From €2838EUR$3,250USD£2,457GBP
- Report
- September 2022
- 30 Pages
Global
From €2838EUR$3,250USD£2,457GBP
- Report
- September 2022
- 30 Pages
Global
From €2401EUR$2,750USD£2,079GBP
- Report
- September 2022
- 30 Pages
Global
From €2401EUR$2,750USD£2,079GBP
- Report
- September 2022
- 30 Pages
Global
From €2401EUR$2,750USD£2,079GBP
- Report
- September 2022
- 30 Pages
Global
From €2401EUR$2,750USD£2,079GBP
- Report
- September 2022
- 30 Pages
Global
From €2401EUR$2,750USD£2,079GBP
- Report
- September 2022
- 51 Pages
Global
From €3449EUR$3,950USD£2,986GBP
- Report
- September 2022
- 70 Pages
Global
From €3449EUR$3,950USD£2,986GBP
- Report
- September 2022
- 135 Pages
Global
From €6548EUR$7,500USD£5,669GBP
- Report
- September 2022
- 103 Pages
Global
From €6548EUR$7,500USD£5,669GBP
- Report
- September 2022
- 79 Pages
Global
From €3449EUR$3,950USD£2,986GBP
- Drug Pipelines
- September 2022
- 30 Pages
Global
From €2401EUR$2,750USD£2,079GBP
- Report
- August 2022
- 30 Pages
Global
From €2838EUR$3,250USD£2,457GBP
- Report
- August 2022
- 30 Pages
Global
From €2401EUR$2,750USD£2,079GBP
- Report
- August 2022
- 218 Pages
Global
From €6548EUR$7,500USD£5,669GBP
- Report
- August 2022
- 109 Pages
Global
From €3449EUR$3,950USD£2,986GBP
- Report
- August 2022
- 30 Pages
Global
From €2838EUR$3,250USD£2,457GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more